Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04106531 · ClinicalTrials.gov registry record
Validation of a Quality of Life Metric "Prolac-10"
A clinical trial, sponsored by Ohio State University.
- Terminated
- Registry status
- 8
- Enrollment target
NCT04106531: Clinical Trial study, sponsored by Ohio State University.
NCT04106531 is a clinical trial that was terminated before completion, run by Ohio State University. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04106531 was terminated before completion, sponsored by Ohio State University.
- TERMINATED
- Registry status
- 8 participants
- Enrollment target
Study Summary
This is a short-term validation study of a quality of life metric "Prolac-10" for patients diagnosed with a prolactinoma, undergoing new medical therapy.
Primary Outcome
In patients diagnosed with a Prolactinoma, validate the novel quality of life questionnaire, Prolac-10 by testing its sensitivity and internal consistency.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2019-10-15 |
| Est. Completion | 2023-06-13 |
Why NCT04106531 stopped before completion
NCT04106531 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04106531 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04106531 about?
NCT04106531 is a clinical study titled "Validation of a Quality of Life Metric "Prolac-10"". This is a short-term validation study of a quality of life metric "Prolac-10" for patients diagnosed with a prolactinoma, undergoing new medical therapy.
What is the current status of trial NCT04106531?
This trial is currently terminated. The enrollment target is 8 participants. The study started on 2019-10-15. Estimated completion is 2023-06-13.
Who is sponsoring clinical trial NCT04106531?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI